A groundbreaking study on the tuberculosis vaccine published in Nature and led by Distinguished Professor of Microbiology and Molecular Genetics JoAnne Flynn is attracting national attention.
The tuberculosis vaccine has been around for nearly 100 years, but isn’t predictably effective against the deadly disease as currently administered. In the new study, Flynn and a large team of Pitt researchers, in collaboration with scientists from the National Institute of Allergy and Infectious Disease, found that giving the vaccine intravenously, instead of injecting it directly into the skin, increased its effectiveness substantially.
The method needs further study before it can be translated to the clinic, but the results have been heralded as “a huge leap forward” in The New York Times.
Read more about the findings in Pittwire.